Amplia Therapeutics Limited
Amplia Therapeutics Limited (INNMF) Stock Competitors & Peer Comparison
See (INNMF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| INNMF | $0.18 | +0.00% | 92.9M | -18.10 | -$0.01 | N/A |
| NONOF | $35.29 | -2.62% | 156B | 9.81 | $3.58 | +4.85% |
| CSLLY | $24.34 | +1.16% | 94B | 15.76 | $1.54 | +3.01% |
| UCBJF | $293.74 | -2.20% | 55.9B | 31.55 | $9.31 | +0.54% |
| UCBJY | $144.61 | +0.45% | 55B | 31.02 | $4.66 | +0.54% |
| ARGNF | $814.94 | +0.00% | 50.4B | 41.66 | $19.56 | N/A |
| CMXHF | $95.56 | -0.47% | 47.8B | 15.96 | $6.17 | +3.03% |
| WXIBF | $4.60 | +0.00% | 19B | 27.06 | $0.17 | N/A |
| IVBXF | $10.62 | +0.05% | 18.3B | 151.71 | $0.07 | N/A |
| WXXWY | $8.10 | +0.62% | 16.7B | 23.79 | $0.34 | N/A |
Stock Comparison
INNMF vs NONOF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, NONOF has a market cap of 156B. Regarding current trading prices, INNMF is priced at $0.18, while NONOF trades at $35.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas NONOF's P/E ratio is 9.81. In terms of profitability, INNMF's ROE is -0.24%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, INNMF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check NONOF's competition here
INNMF vs CSLLY Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, CSLLY has a market cap of 94B. Regarding current trading prices, INNMF is priced at $0.18, while CSLLY trades at $24.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas CSLLY's P/E ratio is 15.76. In terms of profitability, INNMF's ROE is -0.24%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, INNMF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check CSLLY's competition here
INNMF vs UCBJF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, UCBJF has a market cap of 55.9B. Regarding current trading prices, INNMF is priced at $0.18, while UCBJF trades at $293.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas UCBJF's P/E ratio is 31.55. In terms of profitability, INNMF's ROE is -0.24%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, INNMF and UCBJF have similar daily volatility (0.00).Check UCBJF's competition here
INNMF vs UCBJY Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, UCBJY has a market cap of 55B. Regarding current trading prices, INNMF is priced at $0.18, while UCBJY trades at $144.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas UCBJY's P/E ratio is 31.02. In terms of profitability, INNMF's ROE is -0.24%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, INNMF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check UCBJY's competition here
INNMF vs ARGNF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, ARGNF has a market cap of 50.4B. Regarding current trading prices, INNMF is priced at $0.18, while ARGNF trades at $814.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas ARGNF's P/E ratio is 41.66. In terms of profitability, INNMF's ROE is -0.24%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, INNMF and ARGNF have similar daily volatility (0.00).Check ARGNF's competition here
INNMF vs CMXHF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, CMXHF has a market cap of 47.8B. Regarding current trading prices, INNMF is priced at $0.18, while CMXHF trades at $95.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas CMXHF's P/E ratio is 15.96. In terms of profitability, INNMF's ROE is -0.24%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, INNMF is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check CMXHF's competition here
INNMF vs WXIBF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, WXIBF has a market cap of 19B. Regarding current trading prices, INNMF is priced at $0.18, while WXIBF trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas WXIBF's P/E ratio is 27.06. In terms of profitability, INNMF's ROE is -0.24%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, INNMF and WXIBF have similar daily volatility (0.00).Check WXIBF's competition here
INNMF vs IVBXF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, IVBXF has a market cap of 18.3B. Regarding current trading prices, INNMF is priced at $0.18, while IVBXF trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas IVBXF's P/E ratio is 151.71. In terms of profitability, INNMF's ROE is -0.24%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, INNMF and IVBXF have similar daily volatility (0.00).Check IVBXF's competition here
INNMF vs WXXWY Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, WXXWY has a market cap of 16.7B. Regarding current trading prices, INNMF is priced at $0.18, while WXXWY trades at $8.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas WXXWY's P/E ratio is 23.79. In terms of profitability, INNMF's ROE is -0.24%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, INNMF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check WXXWY's competition here
INNMF vs GNMSF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, GNMSF has a market cap of 16.5B. Regarding current trading prices, INNMF is priced at $0.18, while GNMSF trades at $267.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas GNMSF's P/E ratio is 17.40. In terms of profitability, INNMF's ROE is -0.24%, compared to GNMSF's ROE of +0.14%. Regarding short-term risk, INNMF and GNMSF have similar daily volatility (0.00).Check GNMSF's competition here
INNMF vs SBHMY Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, SBHMY has a market cap of 14.2B. Regarding current trading prices, INNMF is priced at $0.18, while SBHMY trades at $15.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas SBHMY's P/E ratio is 41.82. In terms of profitability, INNMF's ROE is -0.24%, compared to SBHMY's ROE of +0.12%. Regarding short-term risk, INNMF and SBHMY have similar daily volatility (0.00).Check SBHMY's competition here
INNMF vs SBMFF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, SBMFF has a market cap of 13.6B. Regarding current trading prices, INNMF is priced at $0.18, while SBMFF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas SBMFF's P/E ratio is 25.28. In terms of profitability, INNMF's ROE is -0.24%, compared to SBMFF's ROE of +0.12%. Regarding short-term risk, INNMF and SBMFF have similar daily volatility (0.00).Check SBMFF's competition here
INNMF vs BRRGF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, INNMF is priced at $0.18, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, INNMF's ROE is -0.24%, compared to BRRGF's ROE of -1.05%. Regarding short-term risk, INNMF is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check BRRGF's competition here
INNMF vs AAVXF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, INNMF is priced at $0.18, while AAVXF trades at $115.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, INNMF's ROE is -0.24%, compared to AAVXF's ROE of +50.78%. Regarding short-term risk, INNMF and AAVXF have similar daily volatility (0.00).Check AAVXF's competition here
INNMF vs ODTC Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, INNMF is priced at $0.18, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas ODTC's P/E ratio is 1.07. In terms of profitability, INNMF's ROE is -0.24%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, INNMF and ODTC have similar daily volatility (0.00).Check ODTC's competition here
INNMF vs AKBLF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, AKBLF has a market cap of 6.5B. Regarding current trading prices, INNMF is priced at $0.18, while AKBLF trades at $32.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas AKBLF's P/E ratio is 38.30. In terms of profitability, INNMF's ROE is -0.24%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, INNMF and AKBLF have similar daily volatility (0.00).Check AKBLF's competition here
INNMF vs REGMF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, REGMF has a market cap of 6.2B. Regarding current trading prices, INNMF is priced at $0.18, while REGMF trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas REGMF's P/E ratio is -35.32. In terms of profitability, INNMF's ROE is -0.24%, compared to REGMF's ROE of +0.33%. Regarding short-term risk, INNMF and REGMF have similar daily volatility (0.00).Check REGMF's competition here
INNMF vs TRSBF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, TRSBF has a market cap of 6.2B. Regarding current trading prices, INNMF is priced at $0.18, while TRSBF trades at $2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas TRSBF's P/E ratio is 18.64. In terms of profitability, INNMF's ROE is -0.24%, compared to TRSBF's ROE of +0.15%. Regarding short-term risk, INNMF and TRSBF have similar daily volatility (0.00).Check TRSBF's competition here
INNMF vs ABCZF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, INNMF is priced at $0.18, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, INNMF's ROE is -0.24%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, INNMF and ABCZF have similar daily volatility (0.00).Check ABCZF's competition here
INNMF vs LABFF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, INNMF is priced at $0.18, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas LABFF's P/E ratio is 28.95. In terms of profitability, INNMF's ROE is -0.24%, compared to LABFF's ROE of +0.23%. Regarding short-term risk, INNMF and LABFF have similar daily volatility (0.00).Check LABFF's competition here
INNMF vs SHJBF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, INNMF is priced at $0.18, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, INNMF's ROE is -0.24%, compared to SHJBF's ROE of -0.14%. Regarding short-term risk, INNMF and SHJBF have similar daily volatility (0.00).Check SHJBF's competition here
INNMF vs CAMRF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, INNMF is priced at $0.18, while CAMRF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas CAMRF's P/E ratio is 41.98. In terms of profitability, INNMF's ROE is -0.24%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, INNMF and CAMRF have similar daily volatility (0.00).Check CAMRF's competition here
INNMF vs ASPHF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, ASPHF has a market cap of 3.1B. Regarding current trading prices, INNMF is priced at $0.18, while ASPHF trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, INNMF's ROE is -0.24%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, INNMF and ASPHF have similar daily volatility (0.00).Check ASPHF's competition here
INNMF vs ZLDPF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, ZLDPF has a market cap of 3.1B. Regarding current trading prices, INNMF is priced at $0.18, while ZLDPF trades at $44.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas ZLDPF's P/E ratio is 3.17. In terms of profitability, INNMF's ROE is -0.24%, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, INNMF and ZLDPF have similar daily volatility (0.00).Check ZLDPF's competition here
INNMF vs TLPPF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, TLPPF has a market cap of 3.1B. Regarding current trading prices, INNMF is priced at $0.18, while TLPPF trades at $9.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas TLPPF's P/E ratio is -460.88. In terms of profitability, INNMF's ROE is -0.24%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, INNMF and TLPPF have similar daily volatility (0.00).Check TLPPF's competition here
INNMF vs GNNSF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, GNNSF has a market cap of 3.1B. Regarding current trading prices, INNMF is priced at $0.18, while GNNSF trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas GNNSF's P/E ratio is -5.68. In terms of profitability, INNMF's ROE is -0.24%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, INNMF and GNNSF have similar daily volatility (0.00).Check GNNSF's competition here
INNMF vs BRCTF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, BRCTF has a market cap of 2.9B. Regarding current trading prices, INNMF is priced at $0.18, while BRCTF trades at $33.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas BRCTF's P/E ratio is 26.63. In terms of profitability, INNMF's ROE is -0.24%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, INNMF and BRCTF have similar daily volatility (0.00).Check BRCTF's competition here
INNMF vs MPSYF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, INNMF is priced at $0.18, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, INNMF's ROE is -0.24%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, INNMF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check MPSYF's competition here
INNMF vs BVNKF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, BVNKF has a market cap of 2.4B. Regarding current trading prices, INNMF is priced at $0.18, while BVNKF trades at $30.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas BVNKF's P/E ratio is 11.20. In terms of profitability, INNMF's ROE is -0.24%, compared to BVNKF's ROE of +0.11%. Regarding short-term risk, INNMF and BVNKF have similar daily volatility (0.00).Check BVNKF's competition here
INNMF vs GENSF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, GENSF has a market cap of 2.4B. Regarding current trading prices, INNMF is priced at $0.18, while GENSF trades at $35.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas GENSF's P/E ratio is 37.86. In terms of profitability, INNMF's ROE is -0.24%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, INNMF and GENSF have similar daily volatility (0.00).Check GENSF's competition here
INNMF vs INCPF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, INNMF is priced at $0.18, while INCPF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas INCPF's P/E ratio is 25.83. In terms of profitability, INNMF's ROE is -0.24%, compared to INCPF's ROE of +0.09%. Regarding short-term risk, INNMF and INCPF have similar daily volatility (0.00).Check INCPF's competition here
INNMF vs BVNRY Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, BVNRY has a market cap of 2.3B. Regarding current trading prices, INNMF is priced at $0.18, while BVNRY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas BVNRY's P/E ratio is 10.60. In terms of profitability, INNMF's ROE is -0.24%, compared to BVNRY's ROE of +0.11%. Regarding short-term risk, INNMF is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check BVNRY's competition here
INNMF vs GLPGF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, GLPGF has a market cap of 2.2B. Regarding current trading prices, INNMF is priced at $0.18, while GLPGF trades at $33.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas GLPGF's P/E ratio is -4.15. In terms of profitability, INNMF's ROE is -0.24%, compared to GLPGF's ROE of +0.11%. Regarding short-term risk, INNMF and GLPGF have similar daily volatility (0.00).Check GLPGF's competition here
INNMF vs MEOBF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, MEOBF has a market cap of 2.1B. Regarding current trading prices, INNMF is priced at $0.18, while MEOBF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas MEOBF's P/E ratio is -22.86. In terms of profitability, INNMF's ROE is -0.24%, compared to MEOBF's ROE of -0.18%. Regarding short-term risk, INNMF and MEOBF have similar daily volatility (0.00).Check MEOBF's competition here
INNMF vs ASCLF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, ASCLF has a market cap of 1.9B. Regarding current trading prices, INNMF is priced at $0.18, while ASCLF trades at $1.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas ASCLF's P/E ratio is -45.25. In terms of profitability, INNMF's ROE is -0.24%, compared to ASCLF's ROE of -0.13%. Regarding short-term risk, INNMF and ASCLF have similar daily volatility (0.00).Check ASCLF's competition here
INNMF vs BIESF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, INNMF is priced at $0.18, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas BIESF's P/E ratio is -44.44. In terms of profitability, INNMF's ROE is -0.24%, compared to BIESF's ROE of -0.07%. Regarding short-term risk, INNMF and BIESF have similar daily volatility (0.00).Check BIESF's competition here
INNMF vs PHMMF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, PHMMF has a market cap of 1.6B. Regarding current trading prices, INNMF is priced at $0.18, while PHMMF trades at $92.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas PHMMF's P/E ratio is 40.08. In terms of profitability, INNMF's ROE is -0.24%, compared to PHMMF's ROE of +0.35%. Regarding short-term risk, INNMF and PHMMF have similar daily volatility (0.00).Check PHMMF's competition here
INNMF vs ONTTF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, ONTTF has a market cap of 1.5B. Regarding current trading prices, INNMF is priced at $0.18, while ONTTF trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas ONTTF's P/E ratio is -7.65. In terms of profitability, INNMF's ROE is -0.24%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, INNMF and ONTTF have similar daily volatility (0.00).Check ONTTF's competition here
INNMF vs CSPHF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, CSPHF has a market cap of 1.5B. Regarding current trading prices, INNMF is priced at $0.18, while CSPHF trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas CSPHF's P/E ratio is -25.25. In terms of profitability, INNMF's ROE is -0.24%, compared to CSPHF's ROE of -0.71%. Regarding short-term risk, INNMF and CSPHF have similar daily volatility (0.00).Check CSPHF's competition here
INNMF vs HBMHF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, INNMF is priced at $0.18, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas HBMHF's P/E ratio is 17.33. In terms of profitability, INNMF's ROE is -0.24%, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, INNMF and HBMHF have similar daily volatility (0.00).Check HBMHF's competition here
INNMF vs SNBIF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, INNMF is priced at $0.18, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, INNMF's ROE is -0.24%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, INNMF and SNBIF have similar daily volatility (0.00).Check SNBIF's competition here
INNMF vs MDCLF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, INNMF is priced at $0.18, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, INNMF's ROE is -0.24%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, INNMF and MDCLF have similar daily volatility (0.00).Check MDCLF's competition here
INNMF vs CSBTF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, CSBTF has a market cap of 1.1B. Regarding current trading prices, INNMF is priced at $0.18, while CSBTF trades at $27.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas CSBTF's P/E ratio is 348.13. In terms of profitability, INNMF's ROE is -0.24%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, INNMF and CSBTF have similar daily volatility (0.00).Check CSBTF's competition here
INNMF vs PHGUF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, PHGUF has a market cap of 1.1B. Regarding current trading prices, INNMF is priced at $0.18, while PHGUF trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas PHGUF's P/E ratio is -151.00. In terms of profitability, INNMF's ROE is -0.24%, compared to PHGUF's ROE of +0.01%. Regarding short-term risk, INNMF and PHGUF have similar daily volatility (0.00).Check PHGUF's competition here
INNMF vs NURPF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, NURPF has a market cap of 1B. Regarding current trading prices, INNMF is priced at $0.18, while NURPF trades at $8.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas NURPF's P/E ratio is 51.38. In terms of profitability, INNMF's ROE is -0.24%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, INNMF and NURPF have similar daily volatility (0.00).Check NURPF's competition here
INNMF vs IDRSF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, IDRSF has a market cap of 1B. Regarding current trading prices, INNMF is priced at $0.18, while IDRSF trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas IDRSF's P/E ratio is -6.11. In terms of profitability, INNMF's ROE is -0.24%, compared to IDRSF's ROE of +0.10%. Regarding short-term risk, INNMF and IDRSF have similar daily volatility (0.00).Check IDRSF's competition here
INNMF vs PPTDF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, PPTDF has a market cap of 1B. Regarding current trading prices, INNMF is priced at $0.18, while PPTDF trades at $7.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas PPTDF's P/E ratio is -43.06. In terms of profitability, INNMF's ROE is -0.24%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, INNMF and PPTDF have similar daily volatility (0.00).Check PPTDF's competition here
INNMF vs BTTAY Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, INNMF is priced at $0.18, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, INNMF's ROE is -0.24%, compared to BTTAY's ROE of -0.07%. Regarding short-term risk, INNMF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check BTTAY's competition here
INNMF vs TKBIF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, INNMF is priced at $0.18, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas TKBIF's P/E ratio is -22.12. In terms of profitability, INNMF's ROE is -0.24%, compared to TKBIF's ROE of N/A. Regarding short-term risk, INNMF and TKBIF have similar daily volatility (0.00).Check TKBIF's competition here
INNMF vs BPMUF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, BPMUF has a market cap of 871.3M. Regarding current trading prices, INNMF is priced at $0.18, while BPMUF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas BPMUF's P/E ratio is 9.97. In terms of profitability, INNMF's ROE is -0.24%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, INNMF and BPMUF have similar daily volatility (0.00).Check BPMUF's competition here
INNMF vs VBIZF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, VBIZF has a market cap of 724.5M. Regarding current trading prices, INNMF is priced at $0.18, while VBIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas VBIZF's P/E ratio is 34.34. In terms of profitability, INNMF's ROE is -0.24%, compared to VBIZF's ROE of +0.04%. Regarding short-term risk, INNMF and VBIZF have similar daily volatility (0.00).Check VBIZF's competition here
INNMF vs IVEVF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, IVEVF has a market cap of 617.4M. Regarding current trading prices, INNMF is priced at $0.18, while IVEVF trades at $4.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas IVEVF's P/E ratio is -1.00. In terms of profitability, INNMF's ROE is -0.24%, compared to IVEVF's ROE of +5.38%. Regarding short-term risk, INNMF and IVEVF have similar daily volatility (0.00).Check IVEVF's competition here
INNMF vs INRLF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, INRLF has a market cap of 602.3M. Regarding current trading prices, INNMF is priced at $0.18, while INRLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas INRLF's P/E ratio is -4.43. In terms of profitability, INNMF's ROE is -0.24%, compared to INRLF's ROE of -0.75%. Regarding short-term risk, INNMF and INRLF have similar daily volatility (0.00).Check INRLF's competition here
INNMF vs CKDXF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, INNMF is priced at $0.18, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, INNMF's ROE is -0.24%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, INNMF and CKDXF have similar daily volatility (0.00).Check CKDXF's competition here
INNMF vs GNFTF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, GNFTF has a market cap of 521.9M. Regarding current trading prices, INNMF is priced at $0.18, while GNFTF trades at $10.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas GNFTF's P/E ratio is -11.46. In terms of profitability, INNMF's ROE is -0.24%, compared to GNFTF's ROE of -0.64%. Regarding short-term risk, INNMF and GNFTF have similar daily volatility (0.00).Check GNFTF's competition here
INNMF vs SOLTF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, SOLTF has a market cap of 477.8M. Regarding current trading prices, INNMF is priced at $0.18, while SOLTF trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas SOLTF's P/E ratio is -6.07. In terms of profitability, INNMF's ROE is -0.24%, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, INNMF and SOLTF have similar daily volatility (0.00).Check SOLTF's competition here
INNMF vs RAONF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, INNMF is priced at $0.18, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas RAONF's P/E ratio is -43.33. In terms of profitability, INNMF's ROE is -0.24%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, INNMF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check RAONF's competition here
INNMF vs GNFTY Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, INNMF is priced at $0.18, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, INNMF's ROE is -0.24%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, INNMF is less volatile compared to GNFTY. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check GNFTY's competition here
INNMF vs TBGNF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, INNMF is priced at $0.18, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, INNMF's ROE is -0.24%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, INNMF and TBGNF have similar daily volatility (0.00).Check TBGNF's competition here
INNMF vs CLVLF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, CLVLF has a market cap of 424.1M. Regarding current trading prices, INNMF is priced at $0.18, while CLVLF trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas CLVLF's P/E ratio is 16.90. In terms of profitability, INNMF's ROE is -0.24%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, INNMF and CLVLF have similar daily volatility (0.00).Check CLVLF's competition here
INNMF vs AVCTF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, AVCTF has a market cap of 379.3M. Regarding current trading prices, INNMF is priced at $0.18, while AVCTF trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas AVCTF's P/E ratio is -5.78. In terms of profitability, INNMF's ROE is -0.24%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, INNMF and AVCTF have similar daily volatility (0.00).Check AVCTF's competition here
INNMF vs PTCHF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, PTCHF has a market cap of 374.8M. Regarding current trading prices, INNMF is priced at $0.18, while PTCHF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas PTCHF's P/E ratio is 9.12. In terms of profitability, INNMF's ROE is -0.24%, compared to PTCHF's ROE of +0.13%. Regarding short-term risk, INNMF and PTCHF have similar daily volatility (0.00).Check PTCHF's competition here
INNMF vs CLVLY Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, CLVLY has a market cap of 356.4M. Regarding current trading prices, INNMF is priced at $0.18, while CLVLY trades at $6.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas CLVLY's P/E ratio is 15.78. In terms of profitability, INNMF's ROE is -0.24%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, INNMF and CLVLY have similar daily volatility (0.00).Check CLVLY's competition here
INNMF vs CYDY Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, CYDY has a market cap of 331.6M. Regarding current trading prices, INNMF is priced at $0.18, while CYDY trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas CYDY's P/E ratio is -8.70. In terms of profitability, INNMF's ROE is -0.24%, compared to CYDY's ROE of +0.38%. Regarding short-term risk, INNMF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check CYDY's competition here
INNMF vs CMVLF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, CMVLF has a market cap of 325.5M. Regarding current trading prices, INNMF is priced at $0.18, while CMVLF trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas CMVLF's P/E ratio is -6.72. In terms of profitability, INNMF's ROE is -0.24%, compared to CMVLF's ROE of -0.70%. Regarding short-term risk, INNMF and CMVLF have similar daily volatility (0.00).Check CMVLF's competition here
INNMF vs NGENF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, INNMF is priced at $0.18, while NGENF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas NGENF's P/E ratio is -15.19. In terms of profitability, INNMF's ROE is -0.24%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, INNMF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check NGENF's competition here
INNMF vs HLOSF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, HLOSF has a market cap of 312.5M. Regarding current trading prices, INNMF is priced at $0.18, while HLOSF trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas HLOSF's P/E ratio is -9.00. In terms of profitability, INNMF's ROE is -0.24%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, INNMF and HLOSF have similar daily volatility (0.00).Check HLOSF's competition here
INNMF vs NWBO Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, NWBO has a market cap of 311.2M. Regarding current trading prices, INNMF is priced at $0.18, while NWBO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas NWBO's P/E ratio is -3.37. In terms of profitability, INNMF's ROE is -0.24%, compared to NWBO's ROE of +0.92%. Regarding short-term risk, INNMF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check NWBO's competition here
INNMF vs FGHQF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, INNMF is priced at $0.18, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, INNMF's ROE is -0.24%, compared to FGHQF's ROE of +0.01%. Regarding short-term risk, INNMF and FGHQF have similar daily volatility (0.00).Check FGHQF's competition here
INNMF vs PBBIF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, INNMF is priced at $0.18, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, INNMF's ROE is -0.24%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, INNMF and PBBIF have similar daily volatility (0.00).Check PBBIF's competition here
INNMF vs SLNCF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, SLNCF has a market cap of 283.4M. Regarding current trading prices, INNMF is priced at $0.18, while SLNCF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas SLNCF's P/E ratio is -3.17. In terms of profitability, INNMF's ROE is -0.24%, compared to SLNCF's ROE of -4.29%. Regarding short-term risk, INNMF and SLNCF have similar daily volatility (0.00).Check SLNCF's competition here
INNMF vs SPHDF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, SPHDF has a market cap of 275.5M. Regarding current trading prices, INNMF is priced at $0.18, while SPHDF trades at $19.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas SPHDF's P/E ratio is -2.87. In terms of profitability, INNMF's ROE is -0.24%, compared to SPHDF's ROE of -5.22%. Regarding short-term risk, INNMF and SPHDF have similar daily volatility (0.00).Check SPHDF's competition here
INNMF vs ORPOF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, INNMF is priced at $0.18, while ORPOF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, INNMF's ROE is -0.24%, compared to ORPOF's ROE of N/A. Regarding short-term risk, INNMF and ORPOF have similar daily volatility (0.00).Check ORPOF's competition here
INNMF vs ORYZF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, ORYZF has a market cap of 258.9M. Regarding current trading prices, INNMF is priced at $0.18, while ORYZF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas ORYZF's P/E ratio is -83.50. In terms of profitability, INNMF's ROE is -0.24%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, INNMF and ORYZF have similar daily volatility (0.00).Check ORYZF's competition here
INNMF vs HNSBF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, INNMF is priced at $0.18, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas HNSBF's P/E ratio is -4.14. In terms of profitability, INNMF's ROE is -0.24%, compared to HNSBF's ROE of +1.24%. Regarding short-term risk, INNMF and HNSBF have similar daily volatility (0.00).Check HNSBF's competition here
INNMF vs NWPHF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, NWPHF has a market cap of 239.5M. Regarding current trading prices, INNMF is priced at $0.18, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas NWPHF's P/E ratio is N/A. In terms of profitability, INNMF's ROE is -0.24%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, INNMF and NWPHF have similar daily volatility (0.00).Check NWPHF's competition here
INNMF vs CAIHF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, CAIHF has a market cap of 217.4M. Regarding current trading prices, INNMF is priced at $0.18, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas CAIHF's P/E ratio is 2.80. In terms of profitability, INNMF's ROE is -0.24%, compared to CAIHF's ROE of +0.12%. Regarding short-term risk, INNMF and CAIHF have similar daily volatility (0.00).Check CAIHF's competition here
INNMF vs BOVNF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, INNMF is priced at $0.18, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, INNMF's ROE is -0.24%, compared to BOVNF's ROE of -0.47%. Regarding short-term risk, INNMF and BOVNF have similar daily volatility (0.00).Check BOVNF's competition here
INNMF vs FPHAF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, INNMF is priced at $0.18, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, INNMF's ROE is -0.24%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, INNMF and FPHAF have similar daily volatility (0.00).Check FPHAF's competition here
INNMF vs KNTPF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, KNTPF has a market cap of 202.9M. Regarding current trading prices, INNMF is priced at $0.18, while KNTPF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas KNTPF's P/E ratio is -7.21. In terms of profitability, INNMF's ROE is -0.24%, compared to KNTPF's ROE of -0.35%. Regarding short-term risk, INNMF and KNTPF have similar daily volatility (0.00).Check KNTPF's competition here
INNMF vs MLLCF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, MLLCF has a market cap of 185.5M. Regarding current trading prices, INNMF is priced at $0.18, while MLLCF trades at $4.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas MLLCF's P/E ratio is -2.37. In terms of profitability, INNMF's ROE is -0.24%, compared to MLLCF's ROE of -0.60%. Regarding short-term risk, INNMF is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check MLLCF's competition here
INNMF vs ADOCY Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, INNMF is priced at $0.18, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, INNMF's ROE is -0.24%, compared to ADOCY's ROE of +1.86%. Regarding short-term risk, INNMF and ADOCY have similar daily volatility (0.00).Check ADOCY's competition here
INNMF vs SCNLF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, SCNLF has a market cap of 151.1M. Regarding current trading prices, INNMF is priced at $0.18, while SCNLF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas SCNLF's P/E ratio is -14.56. In terms of profitability, INNMF's ROE is -0.24%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, INNMF and SCNLF have similar daily volatility (0.00).Check SCNLF's competition here
INNMF vs ATGGF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, ATGGF has a market cap of 143M. Regarding current trading prices, INNMF is priced at $0.18, while ATGGF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas ATGGF's P/E ratio is N/A. In terms of profitability, INNMF's ROE is -0.24%, compared to ATGGF's ROE of -1.34%. Regarding short-term risk, INNMF and ATGGF have similar daily volatility (0.00).Check ATGGF's competition here
INNMF vs BBIXF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, BBIXF has a market cap of 140.2M. Regarding current trading prices, INNMF is priced at $0.18, while BBIXF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas BBIXF's P/E ratio is -12.00. In terms of profitability, INNMF's ROE is -0.24%, compared to BBIXF's ROE of -8.24%. Regarding short-term risk, INNMF and BBIXF have similar daily volatility (0.00).Check BBIXF's competition here
INNMF vs AMGXF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, AMGXF has a market cap of 139.1M. Regarding current trading prices, INNMF is priced at $0.18, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, INNMF's ROE is -0.24%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, INNMF and AMGXF have similar daily volatility (0.00).Check AMGXF's competition here
INNMF vs SPHRF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, SPHRF has a market cap of 138.6M. Regarding current trading prices, INNMF is priced at $0.18, while SPHRF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas SPHRF's P/E ratio is -33.00. In terms of profitability, INNMF's ROE is -0.24%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, INNMF and SPHRF have similar daily volatility (0.00).Check SPHRF's competition here
INNMF vs SPHRY Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, SPHRY has a market cap of 136.5M. Regarding current trading prices, INNMF is priced at $0.18, while SPHRY trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas SPHRY's P/E ratio is -54.17. In terms of profitability, INNMF's ROE is -0.24%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, INNMF and SPHRY have similar daily volatility (0.00).Check SPHRY's competition here
INNMF vs BRIBF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, INNMF is priced at $0.18, while BRIBF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas BRIBF's P/E ratio is -4.70. In terms of profitability, INNMF's ROE is -0.24%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, INNMF and BRIBF have similar daily volatility (0.00).Check BRIBF's competition here
INNMF vs NDTP Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, NDTP has a market cap of 134.4M. Regarding current trading prices, INNMF is priced at $0.18, while NDTP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas NDTP's P/E ratio is -2.90. In terms of profitability, INNMF's ROE is -0.24%, compared to NDTP's ROE of -0.24%. Regarding short-term risk, INNMF is less volatile compared to NDTP. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check NDTP's competition here
INNMF vs HBPCF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, INNMF is priced at $0.18, while HBPCF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas HBPCF's P/E ratio is -34.60. In terms of profitability, INNMF's ROE is -0.24%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, INNMF and HBPCF have similar daily volatility (0.00).Check HBPCF's competition here
INNMF vs TRGNF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, TRGNF has a market cap of 132.1M. Regarding current trading prices, INNMF is priced at $0.18, while TRGNF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas TRGNF's P/E ratio is -3.03. In terms of profitability, INNMF's ROE is -0.24%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, INNMF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check TRGNF's competition here
INNMF vs IPHYF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, IPHYF has a market cap of 128.7M. Regarding current trading prices, INNMF is priced at $0.18, while IPHYF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas IPHYF's P/E ratio is -2.11. In terms of profitability, INNMF's ROE is -0.24%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, INNMF and IPHYF have similar daily volatility (0.00).Check IPHYF's competition here
INNMF vs JWCTF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, JWCTF has a market cap of 127.8M. Regarding current trading prices, INNMF is priced at $0.18, while JWCTF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas JWCTF's P/E ratio is -1.62. In terms of profitability, INNMF's ROE is -0.24%, compared to JWCTF's ROE of -0.59%. Regarding short-term risk, INNMF and JWCTF have similar daily volatility (0.00).Check JWCTF's competition here
INNMF vs AAPGV Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, INNMF is priced at $0.18, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas AAPGV's P/E ratio is N/A. In terms of profitability, INNMF's ROE is -0.24%, compared to AAPGV's ROE of -1.24%. Regarding short-term risk, INNMF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check AAPGV's competition here
INNMF vs PSTTF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, INNMF is priced at $0.18, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, INNMF's ROE is -0.24%, compared to PSTTF's ROE of N/A. Regarding short-term risk, INNMF and PSTTF have similar daily volatility (0.00).Check PSTTF's competition here
INNMF vs MSCLF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, MSCLF has a market cap of 109.3M. Regarding current trading prices, INNMF is priced at $0.18, while MSCLF trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas MSCLF's P/E ratio is 2.75. In terms of profitability, INNMF's ROE is -0.24%, compared to MSCLF's ROE of -0.52%. Regarding short-term risk, INNMF is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check MSCLF's competition here
INNMF vs EPRXF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, INNMF is priced at $0.18, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, INNMF's ROE is -0.24%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, INNMF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for INNMF.Check EPRXF's competition here
INNMF vs ADOIF Comparison April 2026
INNMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNMF stands at 92.9M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, INNMF is priced at $0.18, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNMF currently has a P/E ratio of -18.10, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, INNMF's ROE is -0.24%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, INNMF and ADOIF have similar daily volatility (0.00).Check ADOIF's competition here